TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/27/17 13:12 | 3/23/17 | NK | Nantkwest, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tajak Richard J. | CA | O | CFO | M.d | 0 | 0.00 | 2 | 5 | 63 | 13 | D | -58 | -59 | -43 | -38 | -20 | -11 | 2 | 6 | 5 | 1 | ||||
12/28/16 19:04 | 12/23/16 | NK | Nantkwest, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tajak Richard J. | CA | O | CFO | M.d | 0 | 0.00 | 2 | 5 | 103 | 10 | D | -64 | 1 | -22 | -19 | -6 | -4 | 3 | -1 | 2 | -9 | -38 | |||
9/27/16 19:37 | 9/23/16 | NK | Nantkwest, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tajak Richard J. | CA | O | CFO | M.d | 0 | 0.00 | 3 | 5 | 317 | 7 | D | -51 | -8 | 34 | 3 | -10 | -12 | 0 | 0 | -3 | -18 | -22 | -54 | ||
6/27/16 21:35 | 6/23/16 | NK | Nantkwest, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tajak Richard J. | CA | O | CFO | M.d | 0 | 0.00 | 2 | 5 | 3 | D | -65 | -30 | -9 | -22 | -7 | -6 | 4 | 12 | 13 | 35 | 0 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |